Waiting times between examinations with intravascularly administered contrast media : a review of contrast media pharmacokinetics and updated ESUR Contrast Media Safety Committee guidelines
© 2023. The Author(s)..
The pharmacokinetics of contrast media (CM) will determine how long safe waiting intervals between successive CT or MRI examinations should be. The Contrast Media Safety Committee has reviewed the data on pharmacokinetics of contrast media to suggest safe waiting intervals between successive contrast-enhanced imaging studies in relation to the renal function of the patient. CLINICAL RELEVANCE STATEMENT: Consider a waiting time between elective contrast-enhanced CT and (coronary) angiography with successive iodine-based contrast media administrations in patients with normal renal function (eGFR > 60 mL/min/1.73 m2) of optimally 12 h (near complete clearance of the previously administered iodine-based contrast media) and minimally 4 h (if clinical indication requires rapid follow-up). KEY POINTS: • Pharmacokinetics of contrast media will guide safe waiting times between successive administrations. • Safe waiting times increase with increasing renal insufficiency. • Iodine-based contrast media influence MRI signal intensities and gadolinium-based contrast agents influence CT attenuation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
European radiology - 34(2024), 4 vom: 29. Apr., Seite 2512-2523 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
van der Molen, Aart J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9679TC07X4 |
|---|
| Anmerkungen: |
Date Completed 22.03.2024 Date Revised 09.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00330-023-10085-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363169652 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363169652 | ||
| 003 | DE-627 | ||
| 005 | 20240409232206.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00330-023-10085-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1370.xml |
| 035 | |a (DE-627)NLM363169652 | ||
| 035 | |a (NLM)37823923 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a van der Molen, Aart J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Waiting times between examinations with intravascularly administered contrast media |b a review of contrast media pharmacokinetics and updated ESUR Contrast Media Safety Committee guidelines |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.03.2024 | ||
| 500 | |a Date Revised 09.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a The pharmacokinetics of contrast media (CM) will determine how long safe waiting intervals between successive CT or MRI examinations should be. The Contrast Media Safety Committee has reviewed the data on pharmacokinetics of contrast media to suggest safe waiting intervals between successive contrast-enhanced imaging studies in relation to the renal function of the patient. CLINICAL RELEVANCE STATEMENT: Consider a waiting time between elective contrast-enhanced CT and (coronary) angiography with successive iodine-based contrast media administrations in patients with normal renal function (eGFR > 60 mL/min/1.73 m2) of optimally 12 h (near complete clearance of the previously administered iodine-based contrast media) and minimally 4 h (if clinical indication requires rapid follow-up). KEY POINTS: • Pharmacokinetics of contrast media will guide safe waiting times between successive administrations. • Safe waiting times increase with increasing renal insufficiency. • Iodine-based contrast media influence MRI signal intensities and gadolinium-based contrast agents influence CT attenuation | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Contrast media | |
| 650 | 4 | |a Hepatic insufficiency | |
| 650 | 4 | |a Pharmacokinetics | |
| 650 | 4 | |a Practice guideline | |
| 650 | 4 | |a Renal insufficiency | |
| 650 | 7 | |a Contrast Media |2 NLM | |
| 650 | 7 | |a Iodine |2 NLM | |
| 650 | 7 | |a 9679TC07X4 |2 NLM | |
| 700 | 1 | |a Dekkers, Ilona A |e verfasserin |4 aut | |
| 700 | 1 | |a Geenen, Remy W F |e verfasserin |4 aut | |
| 700 | 1 | |a Bellin, Marie-France |e verfasserin |4 aut | |
| 700 | 1 | |a Bertolotto, Michele |e verfasserin |4 aut | |
| 700 | 1 | |a Brismar, Torkel B |e verfasserin |4 aut | |
| 700 | 1 | |a Correas, Jean-Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Heinz-Peer, Gertraud |e verfasserin |4 aut | |
| 700 | 1 | |a Mahnken, Andreas H |e verfasserin |4 aut | |
| 700 | 1 | |a Quattrocchi, Carlo C |e verfasserin |4 aut | |
| 700 | 1 | |a Radbruch, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Reimer, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Roditi, Giles |e verfasserin |4 aut | |
| 700 | 1 | |a Romanini, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Sebastià, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Stacul, Fulvio |e verfasserin |4 aut | |
| 700 | 1 | |a Clement, Olivier |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European radiology |d 1991 |g 34(2024), 4 vom: 29. Apr., Seite 2512-2523 |w (DE-627)NLM087691310 |x 1432-1084 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2024 |g number:4 |g day:29 |g month:04 |g pages:2512-2523 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00330-023-10085-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2024 |e 4 |b 29 |c 04 |h 2512-2523 | ||